nodes	percent_of_prediction	percent_of_DWPC	metapath
Gadoxetate—ABCC2—epilepsy syndrome	0.323	1	CbGaD
Gadoxetate—ABCC3—Phenobarbital—epilepsy syndrome	0.111	0.284	CbGbCtD
Gadoxetate—ABCC2—Levetiracetam—epilepsy syndrome	0.11	0.281	CbGbCtD
Gadoxetate—ABCC2—Carbamazepine—epilepsy syndrome	0.063	0.161	CbGbCtD
Gadoxetate—ABCC2—Phenytoin—epilepsy syndrome	0.0565	0.145	CbGbCtD
Gadoxetate—ABCC2—Phenobarbital—epilepsy syndrome	0.0503	0.129	CbGbCtD
Gadoxetate—Gadofosveset trisodium—ALB—epilepsy syndrome	0.000881	1	CrCbGaD
Gadoxetate—Syncope—Pregabalin—epilepsy syndrome	7.36e-05	0.000366	CcSEcCtD
Gadoxetate—Rash—Fosphenytoin—epilepsy syndrome	7.32e-05	0.000364	CcSEcCtD
Gadoxetate—Dermatitis—Fosphenytoin—epilepsy syndrome	7.32e-05	0.000364	CcSEcCtD
Gadoxetate—Asthenia—Clonazepam—epilepsy syndrome	7.3e-05	0.000363	CcSEcCtD
Gadoxetate—Rhinitis—Topiramate—epilepsy syndrome	7.29e-05	0.000363	CcSEcCtD
Gadoxetate—Back pain—Gabapentin—epilepsy syndrome	7.28e-05	0.000362	CcSEcCtD
Gadoxetate—Headache—Fosphenytoin—epilepsy syndrome	7.28e-05	0.000362	CcSEcCtD
Gadoxetate—Nervous system disorder—Valproic Acid—epilepsy syndrome	7.27e-05	0.000361	CcSEcCtD
Gadoxetate—Palpitations—Pregabalin—epilepsy syndrome	7.25e-05	0.000361	CcSEcCtD
Gadoxetate—Asthenia—Phenytoin—epilepsy syndrome	7.25e-05	0.000361	CcSEcCtD
Gadoxetate—Nausea—Midazolam—epilepsy syndrome	7.24e-05	0.00036	CcSEcCtD
Gadoxetate—Hypoaesthesia—Topiramate—epilepsy syndrome	7.24e-05	0.00036	CcSEcCtD
Gadoxetate—Tachycardia—Valproic Acid—epilepsy syndrome	7.23e-05	0.00036	CcSEcCtD
Gadoxetate—Diarrhoea—Zonisamide—epilepsy syndrome	7.23e-05	0.000359	CcSEcCtD
Gadoxetate—Loss of consciousness—Pregabalin—epilepsy syndrome	7.22e-05	0.000359	CcSEcCtD
Gadoxetate—Asthenia—Oxcarbazepine—epilepsy syndrome	7.21e-05	0.000359	CcSEcCtD
Gadoxetate—Pruritus—Clonazepam—epilepsy syndrome	7.2e-05	0.000358	CcSEcCtD
Gadoxetate—Vomiting—Vigabatrin—epilepsy syndrome	7.2e-05	0.000358	CcSEcCtD
Gadoxetate—Skin disorder—Valproic Acid—epilepsy syndrome	7.2e-05	0.000358	CcSEcCtD
Gadoxetate—Hyperhidrosis—Valproic Acid—epilepsy syndrome	7.16e-05	0.000356	CcSEcCtD
Gadoxetate—Cough—Pregabalin—epilepsy syndrome	7.16e-05	0.000356	CcSEcCtD
Gadoxetate—Pruritus—Phenytoin—epilepsy syndrome	7.15e-05	0.000356	CcSEcCtD
Gadoxetate—Connective tissue disorder—Topiramate—epilepsy syndrome	7.15e-05	0.000355	CcSEcCtD
Gadoxetate—Nausea—Levetiracetam—epilepsy syndrome	7.15e-05	0.000355	CcSEcCtD
Gadoxetate—Rash—Vigabatrin—epilepsy syndrome	7.14e-05	0.000355	CcSEcCtD
Gadoxetate—Dizziness—Felbamate—epilepsy syndrome	7.13e-05	0.000355	CcSEcCtD
Gadoxetate—Dermatitis—Vigabatrin—epilepsy syndrome	7.13e-05	0.000355	CcSEcCtD
Gadoxetate—Pruritus—Oxcarbazepine—epilepsy syndrome	7.11e-05	0.000354	CcSEcCtD
Gadoxetate—Convulsion—Pregabalin—epilepsy syndrome	7.11e-05	0.000354	CcSEcCtD
Gadoxetate—Hypersensitivity—Carbamazepine—epilepsy syndrome	7.11e-05	0.000353	CcSEcCtD
Gadoxetate—Vision blurred—Gabapentin—epilepsy syndrome	7.09e-05	0.000353	CcSEcCtD
Gadoxetate—Headache—Vigabatrin—epilepsy syndrome	7.09e-05	0.000353	CcSEcCtD
Gadoxetate—Vomiting—Diazepam—epilepsy syndrome	7.09e-05	0.000352	CcSEcCtD
Gadoxetate—Anorexia—Valproic Acid—epilepsy syndrome	7.06e-05	0.000351	CcSEcCtD
Gadoxetate—Tremor—Gabapentin—epilepsy syndrome	7.05e-05	0.000351	CcSEcCtD
Gadoxetate—Rash—Diazepam—epilepsy syndrome	7.03e-05	0.000349	CcSEcCtD
Gadoxetate—Dermatitis—Diazepam—epilepsy syndrome	7.02e-05	0.000349	CcSEcCtD
Gadoxetate—Chest pain—Pregabalin—epilepsy syndrome	6.99e-05	0.000347	CcSEcCtD
Gadoxetate—Ill-defined disorder—Gabapentin—epilepsy syndrome	6.98e-05	0.000347	CcSEcCtD
Gadoxetate—Dizziness—Zonisamide—epilepsy syndrome	6.98e-05	0.000347	CcSEcCtD
Gadoxetate—Headache—Diazepam—epilepsy syndrome	6.98e-05	0.000347	CcSEcCtD
Gadoxetate—Anxiety—Pregabalin—epilepsy syndrome	6.96e-05	0.000346	CcSEcCtD
Gadoxetate—Diarrhoea—Clonazepam—epilepsy syndrome	6.96e-05	0.000346	CcSEcCtD
Gadoxetate—Unspecified disorder of skin and subcutaneous tissue—Pregabalin—epilepsy syndrome	6.94e-05	0.000345	CcSEcCtD
Gadoxetate—Hypotension—Valproic Acid—epilepsy syndrome	6.93e-05	0.000344	CcSEcCtD
Gadoxetate—Asthenia—Carbamazepine—epilepsy syndrome	6.92e-05	0.000344	CcSEcCtD
Gadoxetate—Agitation—Gabapentin—epilepsy syndrome	6.92e-05	0.000344	CcSEcCtD
Gadoxetate—Diarrhoea—Phenytoin—epilepsy syndrome	6.92e-05	0.000344	CcSEcCtD
Gadoxetate—Discomfort—Pregabalin—epilepsy syndrome	6.91e-05	0.000343	CcSEcCtD
Gadoxetate—Nausea—Fosphenytoin—epilepsy syndrome	6.9e-05	0.000343	CcSEcCtD
Gadoxetate—Diarrhoea—Oxcarbazepine—epilepsy syndrome	6.88e-05	0.000342	CcSEcCtD
Gadoxetate—Hypersensitivity—Lamotrigine—epilepsy syndrome	6.87e-05	0.000342	CcSEcCtD
Gadoxetate—Vomiting—Felbamate—epilepsy syndrome	6.86e-05	0.000341	CcSEcCtD
Gadoxetate—Dry mouth—Pregabalin—epilepsy syndrome	6.84e-05	0.00034	CcSEcCtD
Gadoxetate—Pruritus—Carbamazepine—epilepsy syndrome	6.83e-05	0.000339	CcSEcCtD
Gadoxetate—Rash—Felbamate—epilepsy syndrome	6.8e-05	0.000338	CcSEcCtD
Gadoxetate—Dermatitis—Felbamate—epilepsy syndrome	6.8e-05	0.000338	CcSEcCtD
Gadoxetate—Malaise—Gabapentin—epilepsy syndrome	6.79e-05	0.000337	CcSEcCtD
Gadoxetate—Vertigo—Gabapentin—epilepsy syndrome	6.76e-05	0.000336	CcSEcCtD
Gadoxetate—Headache—Felbamate—epilepsy syndrome	6.76e-05	0.000336	CcSEcCtD
Gadoxetate—Flushing—Topiramate—epilepsy syndrome	6.75e-05	0.000336	CcSEcCtD
Gadoxetate—Cardiac disorder—Topiramate—epilepsy syndrome	6.75e-05	0.000336	CcSEcCtD
Gadoxetate—Syncope—Gabapentin—epilepsy syndrome	6.75e-05	0.000336	CcSEcCtD
Gadoxetate—Dizziness—Clonazepam—epilepsy syndrome	6.73e-05	0.000335	CcSEcCtD
Gadoxetate—Nausea—Vigabatrin—epilepsy syndrome	6.73e-05	0.000334	CcSEcCtD
Gadoxetate—Vomiting—Zonisamide—epilepsy syndrome	6.71e-05	0.000334	CcSEcCtD
Gadoxetate—Oedema—Pregabalin—epilepsy syndrome	6.7e-05	0.000333	CcSEcCtD
Gadoxetate—Anaphylactic shock—Pregabalin—epilepsy syndrome	6.7e-05	0.000333	CcSEcCtD
Gadoxetate—Asthenia—Lamotrigine—epilepsy syndrome	6.69e-05	0.000333	CcSEcCtD
Gadoxetate—Dizziness—Phenytoin—epilepsy syndrome	6.69e-05	0.000332	CcSEcCtD
Gadoxetate—Rash—Zonisamide—epilepsy syndrome	6.66e-05	0.000331	CcSEcCtD
Gadoxetate—Infection—Pregabalin—epilepsy syndrome	6.66e-05	0.000331	CcSEcCtD
Gadoxetate—Paraesthesia—Valproic Acid—epilepsy syndrome	6.65e-05	0.000331	CcSEcCtD
Gadoxetate—Palpitations—Gabapentin—epilepsy syndrome	6.65e-05	0.000331	CcSEcCtD
Gadoxetate—Dermatitis—Zonisamide—epilepsy syndrome	6.65e-05	0.000331	CcSEcCtD
Gadoxetate—Dizziness—Oxcarbazepine—epilepsy syndrome	6.65e-05	0.000331	CcSEcCtD
Gadoxetate—Nausea—Diazepam—epilepsy syndrome	6.62e-05	0.000329	CcSEcCtD
Gadoxetate—Loss of consciousness—Gabapentin—epilepsy syndrome	6.62e-05	0.000329	CcSEcCtD
Gadoxetate—Headache—Zonisamide—epilepsy syndrome	6.62e-05	0.000329	CcSEcCtD
Gadoxetate—Dyspnoea—Valproic Acid—epilepsy syndrome	6.61e-05	0.000328	CcSEcCtD
Gadoxetate—Diarrhoea—Carbamazepine—epilepsy syndrome	6.6e-05	0.000328	CcSEcCtD
Gadoxetate—Angiopathy—Topiramate—epilepsy syndrome	6.6e-05	0.000328	CcSEcCtD
Gadoxetate—Pruritus—Lamotrigine—epilepsy syndrome	6.6e-05	0.000328	CcSEcCtD
Gadoxetate—Shock—Pregabalin—epilepsy syndrome	6.59e-05	0.000328	CcSEcCtD
Gadoxetate—Immune system disorder—Topiramate—epilepsy syndrome	6.57e-05	0.000327	CcSEcCtD
Gadoxetate—Nervous system disorder—Pregabalin—epilepsy syndrome	6.57e-05	0.000327	CcSEcCtD
Gadoxetate—Cough—Gabapentin—epilepsy syndrome	6.57e-05	0.000327	CcSEcCtD
Gadoxetate—Mediastinal disorder—Topiramate—epilepsy syndrome	6.56e-05	0.000326	CcSEcCtD
Gadoxetate—Tachycardia—Pregabalin—epilepsy syndrome	6.54e-05	0.000325	CcSEcCtD
Gadoxetate—Chills—Topiramate—epilepsy syndrome	6.53e-05	0.000325	CcSEcCtD
Gadoxetate—Convulsion—Gabapentin—epilepsy syndrome	6.52e-05	0.000324	CcSEcCtD
Gadoxetate—Skin disorder—Pregabalin—epilepsy syndrome	6.51e-05	0.000324	CcSEcCtD
Gadoxetate—Hyperhidrosis—Pregabalin—epilepsy syndrome	6.48e-05	0.000322	CcSEcCtD
Gadoxetate—Vomiting—Clonazepam—epilepsy syndrome	6.47e-05	0.000322	CcSEcCtD
Gadoxetate—Decreased appetite—Valproic Acid—epilepsy syndrome	6.44e-05	0.00032	CcSEcCtD
Gadoxetate—Vomiting—Phenytoin—epilepsy syndrome	6.43e-05	0.00032	CcSEcCtD
Gadoxetate—Rash—Clonazepam—epilepsy syndrome	6.42e-05	0.000319	CcSEcCtD
Gadoxetate—Dermatitis—Clonazepam—epilepsy syndrome	6.41e-05	0.000319	CcSEcCtD
Gadoxetate—Chest pain—Gabapentin—epilepsy syndrome	6.41e-05	0.000319	CcSEcCtD
Gadoxetate—Nausea—Felbamate—epilepsy syndrome	6.41e-05	0.000319	CcSEcCtD
Gadoxetate—Gastrointestinal disorder—Valproic Acid—epilepsy syndrome	6.4e-05	0.000318	CcSEcCtD
Gadoxetate—Vomiting—Oxcarbazepine—epilepsy syndrome	6.39e-05	0.000318	CcSEcCtD
Gadoxetate—Fatigue—Valproic Acid—epilepsy syndrome	6.39e-05	0.000318	CcSEcCtD
Gadoxetate—Anxiety—Gabapentin—epilepsy syndrome	6.39e-05	0.000318	CcSEcCtD
Gadoxetate—Anorexia—Pregabalin—epilepsy syndrome	6.39e-05	0.000317	CcSEcCtD
Gadoxetate—Dizziness—Carbamazepine—epilepsy syndrome	6.38e-05	0.000317	CcSEcCtD
Gadoxetate—Diarrhoea—Lamotrigine—epilepsy syndrome	6.38e-05	0.000317	CcSEcCtD
Gadoxetate—Headache—Clonazepam—epilepsy syndrome	6.38e-05	0.000317	CcSEcCtD
Gadoxetate—Rash—Phenytoin—epilepsy syndrome	6.37e-05	0.000317	CcSEcCtD
Gadoxetate—Dermatitis—Phenytoin—epilepsy syndrome	6.37e-05	0.000317	CcSEcCtD
Gadoxetate—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—epilepsy syndrome	6.36e-05	0.000316	CcSEcCtD
Gadoxetate—Rash—Oxcarbazepine—epilepsy syndrome	6.34e-05	0.000315	CcSEcCtD
Gadoxetate—Constipation—Valproic Acid—epilepsy syndrome	6.34e-05	0.000315	CcSEcCtD
Gadoxetate—Dermatitis—Oxcarbazepine—epilepsy syndrome	6.33e-05	0.000315	CcSEcCtD
Gadoxetate—Headache—Phenytoin—epilepsy syndrome	6.33e-05	0.000315	CcSEcCtD
Gadoxetate—Discomfort—Gabapentin—epilepsy syndrome	6.33e-05	0.000315	CcSEcCtD
Gadoxetate—Headache—Oxcarbazepine—epilepsy syndrome	6.3e-05	0.000313	CcSEcCtD
Gadoxetate—Nausea—Zonisamide—epilepsy syndrome	6.27e-05	0.000312	CcSEcCtD
Gadoxetate—Dry mouth—Gabapentin—epilepsy syndrome	6.27e-05	0.000312	CcSEcCtD
Gadoxetate—Hypotension—Pregabalin—epilepsy syndrome	6.26e-05	0.000311	CcSEcCtD
Gadoxetate—Flatulence—Topiramate—epilepsy syndrome	6.24e-05	0.00031	CcSEcCtD
Gadoxetate—Dysgeusia—Topiramate—epilepsy syndrome	6.2e-05	0.000308	CcSEcCtD
Gadoxetate—Dizziness—Lamotrigine—epilepsy syndrome	6.17e-05	0.000307	CcSEcCtD
Gadoxetate—Oedema—Gabapentin—epilepsy syndrome	6.14e-05	0.000305	CcSEcCtD
Gadoxetate—Anaphylactic shock—Gabapentin—epilepsy syndrome	6.14e-05	0.000305	CcSEcCtD
Gadoxetate—Vomiting—Carbamazepine—epilepsy syndrome	6.14e-05	0.000305	CcSEcCtD
Gadoxetate—Back pain—Topiramate—epilepsy syndrome	6.13e-05	0.000305	CcSEcCtD
Gadoxetate—Feeling abnormal—Valproic Acid—epilepsy syndrome	6.11e-05	0.000304	CcSEcCtD
Gadoxetate—Infection—Gabapentin—epilepsy syndrome	6.1e-05	0.000303	CcSEcCtD
Gadoxetate—Rash—Carbamazepine—epilepsy syndrome	6.08e-05	0.000302	CcSEcCtD
Gadoxetate—Dermatitis—Carbamazepine—epilepsy syndrome	6.08e-05	0.000302	CcSEcCtD
Gadoxetate—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	6.06e-05	0.000301	CcSEcCtD
Gadoxetate—Nausea—Clonazepam—epilepsy syndrome	6.05e-05	0.000301	CcSEcCtD
Gadoxetate—Headache—Carbamazepine—epilepsy syndrome	6.05e-05	0.000301	CcSEcCtD
Gadoxetate—Shock—Gabapentin—epilepsy syndrome	6.04e-05	0.0003	CcSEcCtD
Gadoxetate—Nervous system disorder—Gabapentin—epilepsy syndrome	6.02e-05	0.0003	CcSEcCtD
Gadoxetate—Paraesthesia—Pregabalin—epilepsy syndrome	6.02e-05	0.000299	CcSEcCtD
Gadoxetate—Nausea—Phenytoin—epilepsy syndrome	6e-05	0.000299	CcSEcCtD
Gadoxetate—Tachycardia—Gabapentin—epilepsy syndrome	6e-05	0.000298	CcSEcCtD
Gadoxetate—Dyspnoea—Pregabalin—epilepsy syndrome	5.97e-05	0.000297	CcSEcCtD
Gadoxetate—Nausea—Oxcarbazepine—epilepsy syndrome	5.97e-05	0.000297	CcSEcCtD
Gadoxetate—Vision blurred—Topiramate—epilepsy syndrome	5.97e-05	0.000297	CcSEcCtD
Gadoxetate—Skin disorder—Gabapentin—epilepsy syndrome	5.97e-05	0.000297	CcSEcCtD
Gadoxetate—Hyperhidrosis—Gabapentin—epilepsy syndrome	5.94e-05	0.000295	CcSEcCtD
Gadoxetate—Tremor—Topiramate—epilepsy syndrome	5.93e-05	0.000295	CcSEcCtD
Gadoxetate—Vomiting—Lamotrigine—epilepsy syndrome	5.93e-05	0.000295	CcSEcCtD
Gadoxetate—Urticaria—Valproic Acid—epilepsy syndrome	5.89e-05	0.000293	CcSEcCtD
Gadoxetate—Rash—Lamotrigine—epilepsy syndrome	5.88e-05	0.000292	CcSEcCtD
Gadoxetate—Ill-defined disorder—Topiramate—epilepsy syndrome	5.88e-05	0.000292	CcSEcCtD
Gadoxetate—Dermatitis—Lamotrigine—epilepsy syndrome	5.87e-05	0.000292	CcSEcCtD
Gadoxetate—Abdominal pain—Valproic Acid—epilepsy syndrome	5.86e-05	0.000291	CcSEcCtD
Gadoxetate—Body temperature increased—Valproic Acid—epilepsy syndrome	5.86e-05	0.000291	CcSEcCtD
Gadoxetate—Anorexia—Gabapentin—epilepsy syndrome	5.86e-05	0.000291	CcSEcCtD
Gadoxetate—Headache—Lamotrigine—epilepsy syndrome	5.84e-05	0.00029	CcSEcCtD
Gadoxetate—Decreased appetite—Pregabalin—epilepsy syndrome	5.82e-05	0.00029	CcSEcCtD
Gadoxetate—Agitation—Topiramate—epilepsy syndrome	5.82e-05	0.000289	CcSEcCtD
Gadoxetate—Gastrointestinal disorder—Pregabalin—epilepsy syndrome	5.78e-05	0.000288	CcSEcCtD
Gadoxetate—Fatigue—Pregabalin—epilepsy syndrome	5.78e-05	0.000287	CcSEcCtD
Gadoxetate—Hypotension—Gabapentin—epilepsy syndrome	5.74e-05	0.000285	CcSEcCtD
Gadoxetate—Nausea—Carbamazepine—epilepsy syndrome	5.73e-05	0.000285	CcSEcCtD
Gadoxetate—Constipation—Pregabalin—epilepsy syndrome	5.73e-05	0.000285	CcSEcCtD
Gadoxetate—Malaise—Topiramate—epilepsy syndrome	5.71e-05	0.000284	CcSEcCtD
Gadoxetate—Vertigo—Topiramate—epilepsy syndrome	5.69e-05	0.000283	CcSEcCtD
Gadoxetate—Syncope—Topiramate—epilepsy syndrome	5.68e-05	0.000282	CcSEcCtD
Gadoxetate—Palpitations—Topiramate—epilepsy syndrome	5.6e-05	0.000278	CcSEcCtD
Gadoxetate—Loss of consciousness—Topiramate—epilepsy syndrome	5.57e-05	0.000277	CcSEcCtD
Gadoxetate—Nausea—Lamotrigine—epilepsy syndrome	5.54e-05	0.000275	CcSEcCtD
Gadoxetate—Cough—Topiramate—epilepsy syndrome	5.53e-05	0.000275	CcSEcCtD
Gadoxetate—Feeling abnormal—Pregabalin—epilepsy syndrome	5.52e-05	0.000274	CcSEcCtD
Gadoxetate—Paraesthesia—Gabapentin—epilepsy syndrome	5.52e-05	0.000274	CcSEcCtD
Gadoxetate—Convulsion—Topiramate—epilepsy syndrome	5.49e-05	0.000273	CcSEcCtD
Gadoxetate—Gastrointestinal pain—Pregabalin—epilepsy syndrome	5.48e-05	0.000272	CcSEcCtD
Gadoxetate—Dyspnoea—Gabapentin—epilepsy syndrome	5.48e-05	0.000272	CcSEcCtD
Gadoxetate—Hypersensitivity—Valproic Acid—epilepsy syndrome	5.46e-05	0.000271	CcSEcCtD
Gadoxetate—Chest pain—Topiramate—epilepsy syndrome	5.39e-05	0.000268	CcSEcCtD
Gadoxetate—Anxiety—Topiramate—epilepsy syndrome	5.37e-05	0.000267	CcSEcCtD
Gadoxetate—Unspecified disorder of skin and subcutaneous tissue—Topiramate—epilepsy syndrome	5.35e-05	0.000266	CcSEcCtD
Gadoxetate—Decreased appetite—Gabapentin—epilepsy syndrome	5.34e-05	0.000266	CcSEcCtD
Gadoxetate—Discomfort—Topiramate—epilepsy syndrome	5.33e-05	0.000265	CcSEcCtD
Gadoxetate—Urticaria—Pregabalin—epilepsy syndrome	5.32e-05	0.000265	CcSEcCtD
Gadoxetate—Asthenia—Valproic Acid—epilepsy syndrome	5.32e-05	0.000264	CcSEcCtD
Gadoxetate—Gastrointestinal disorder—Gabapentin—epilepsy syndrome	5.3e-05	0.000264	CcSEcCtD
Gadoxetate—Fatigue—Gabapentin—epilepsy syndrome	5.3e-05	0.000263	CcSEcCtD
Gadoxetate—Abdominal pain—Pregabalin—epilepsy syndrome	5.3e-05	0.000263	CcSEcCtD
Gadoxetate—Body temperature increased—Pregabalin—epilepsy syndrome	5.3e-05	0.000263	CcSEcCtD
Gadoxetate—Dry mouth—Topiramate—epilepsy syndrome	5.27e-05	0.000262	CcSEcCtD
Gadoxetate—Constipation—Gabapentin—epilepsy syndrome	5.25e-05	0.000261	CcSEcCtD
Gadoxetate—Pruritus—Valproic Acid—epilepsy syndrome	5.24e-05	0.000261	CcSEcCtD
Gadoxetate—Oedema—Topiramate—epilepsy syndrome	5.17e-05	0.000257	CcSEcCtD
Gadoxetate—Infection—Topiramate—epilepsy syndrome	5.13e-05	0.000255	CcSEcCtD
Gadoxetate—Shock—Topiramate—epilepsy syndrome	5.09e-05	0.000253	CcSEcCtD
Gadoxetate—Diarrhoea—Valproic Acid—epilepsy syndrome	5.07e-05	0.000252	CcSEcCtD
Gadoxetate—Nervous system disorder—Topiramate—epilepsy syndrome	5.07e-05	0.000252	CcSEcCtD
Gadoxetate—Feeling abnormal—Gabapentin—epilepsy syndrome	5.06e-05	0.000252	CcSEcCtD
Gadoxetate—Tachycardia—Topiramate—epilepsy syndrome	5.04e-05	0.000251	CcSEcCtD
Gadoxetate—Gastrointestinal pain—Gabapentin—epilepsy syndrome	5.02e-05	0.00025	CcSEcCtD
Gadoxetate—Skin disorder—Topiramate—epilepsy syndrome	5.02e-05	0.00025	CcSEcCtD
Gadoxetate—Hyperhidrosis—Topiramate—epilepsy syndrome	5e-05	0.000248	CcSEcCtD
Gadoxetate—Hypersensitivity—Pregabalin—epilepsy syndrome	4.94e-05	0.000245	CcSEcCtD
Gadoxetate—Anorexia—Topiramate—epilepsy syndrome	4.93e-05	0.000245	CcSEcCtD
Gadoxetate—Dizziness—Valproic Acid—epilepsy syndrome	4.9e-05	0.000244	CcSEcCtD
Gadoxetate—Urticaria—Gabapentin—epilepsy syndrome	4.88e-05	0.000243	CcSEcCtD
Gadoxetate—Body temperature increased—Gabapentin—epilepsy syndrome	4.86e-05	0.000241	CcSEcCtD
Gadoxetate—Abdominal pain—Gabapentin—epilepsy syndrome	4.86e-05	0.000241	CcSEcCtD
Gadoxetate—Hypotension—Topiramate—epilepsy syndrome	4.83e-05	0.00024	CcSEcCtD
Gadoxetate—Asthenia—Pregabalin—epilepsy syndrome	4.81e-05	0.000239	CcSEcCtD
Gadoxetate—Pruritus—Pregabalin—epilepsy syndrome	4.74e-05	0.000236	CcSEcCtD
Gadoxetate—Vomiting—Valproic Acid—epilepsy syndrome	4.71e-05	0.000234	CcSEcCtD
Gadoxetate—ABCC3—Metabolism—COX3—epilepsy syndrome	4.69e-05	0.000553	CbGpPWpGaD
Gadoxetate—ABCC4—Transmembrane transport of small molecules—ABCC2—epilepsy syndrome	4.69e-05	0.000553	CbGpPWpGaD
Gadoxetate—Rash—Valproic Acid—epilepsy syndrome	4.67e-05	0.000232	CcSEcCtD
Gadoxetate—Dermatitis—Valproic Acid—epilepsy syndrome	4.67e-05	0.000232	CcSEcCtD
Gadoxetate—Headache—Valproic Acid—epilepsy syndrome	4.64e-05	0.000231	CcSEcCtD
Gadoxetate—Paraesthesia—Topiramate—epilepsy syndrome	4.64e-05	0.000231	CcSEcCtD
Gadoxetate—SLCO1B1—Metabolism of lipids and lipoproteins—TXNRD1—epilepsy syndrome	4.64e-05	0.000547	CbGpPWpGaD
Gadoxetate—ABCC3—Transmembrane transport of small molecules—SLC6A1—epilepsy syndrome	4.64e-05	0.000547	CbGpPWpGaD
Gadoxetate—ABCC2—Transmembrane transport of small molecules—GABRB2—epilepsy syndrome	4.63e-05	0.000545	CbGpPWpGaD
Gadoxetate—Dyspnoea—Topiramate—epilepsy syndrome	4.61e-05	0.000229	CcSEcCtD
Gadoxetate—Diarrhoea—Pregabalin—epilepsy syndrome	4.58e-05	0.000228	CcSEcCtD
Gadoxetate—SLCO1B3—Transmembrane transport of small molecules—ATP2A2—epilepsy syndrome	4.58e-05	0.00054	CbGpPWpGaD
Gadoxetate—ABCC2—Transmembrane transport of small molecules—AQP1—epilepsy syndrome	4.56e-05	0.000538	CbGpPWpGaD
Gadoxetate—SLCO1B1—Transmembrane transport of small molecules—SLC1A2—epilepsy syndrome	4.56e-05	0.000537	CbGpPWpGaD
Gadoxetate—Hypersensitivity—Gabapentin—epilepsy syndrome	4.53e-05	0.000225	CcSEcCtD
Gadoxetate—SLCO1B3—Metabolism—ATIC—epilepsy syndrome	4.51e-05	0.000531	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—UPB1—epilepsy syndrome	4.51e-05	0.000531	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—NEU1—epilepsy syndrome	4.51e-05	0.000531	CbGpPWpGaD
Gadoxetate—Decreased appetite—Topiramate—epilepsy syndrome	4.49e-05	0.000223	CcSEcCtD
Gadoxetate—ABCC4—Hemostasis—ATP2A2—epilepsy syndrome	4.49e-05	0.000529	CbGpPWpGaD
Gadoxetate—Gastrointestinal disorder—Topiramate—epilepsy syndrome	4.46e-05	0.000222	CcSEcCtD
Gadoxetate—Fatigue—Topiramate—epilepsy syndrome	4.46e-05	0.000222	CcSEcCtD
Gadoxetate—ABCC3—Metabolism—KCNB1—epilepsy syndrome	4.45e-05	0.000524	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—CACNA2D2—epilepsy syndrome	4.45e-05	0.000524	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—SLC6A8—epilepsy syndrome	4.45e-05	0.000524	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—PFKL—epilepsy syndrome	4.45e-05	0.000524	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—SLCO1A2—epilepsy syndrome	4.45e-05	0.000524	CbGpPWpGaD
Gadoxetate—ABCC2—Transmembrane transport of small molecules—TRPV1—epilepsy syndrome	4.44e-05	0.000523	CbGpPWpGaD
Gadoxetate—Dizziness—Pregabalin—epilepsy syndrome	4.43e-05	0.00022	CcSEcCtD
Gadoxetate—Constipation—Topiramate—epilepsy syndrome	4.42e-05	0.00022	CcSEcCtD
Gadoxetate—Asthenia—Gabapentin—epilepsy syndrome	4.41e-05	0.000219	CcSEcCtD
Gadoxetate—Nausea—Valproic Acid—epilepsy syndrome	4.4e-05	0.000219	CcSEcCtD
Gadoxetate—SLCO1B1—Metabolism—GLUD1—epilepsy syndrome	4.37e-05	0.000515	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—ADK—epilepsy syndrome	4.37e-05	0.000515	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—L2HGDH—epilepsy syndrome	4.37e-05	0.000515	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—PDXK—epilepsy syndrome	4.37e-05	0.000515	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—FAR1—epilepsy syndrome	4.37e-05	0.000515	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—CERS1—epilepsy syndrome	4.37e-05	0.000515	CbGpPWpGaD
Gadoxetate—ABCC4—Transmembrane transport of small molecules—SLC6A1—epilepsy syndrome	4.36e-05	0.000514	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—ITGA2—epilepsy syndrome	4.36e-05	0.000513	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism of lipids and lipoproteins—CYP2C19—epilepsy syndrome	4.35e-05	0.000512	CbGpPWpGaD
Gadoxetate—Pruritus—Gabapentin—epilepsy syndrome	4.35e-05	0.000216	CcSEcCtD
Gadoxetate—SLCO1B1—Transmembrane transport of small molecules—GABRB2—epilepsy syndrome	4.35e-05	0.000512	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—HSD17B4—epilepsy syndrome	4.34e-05	0.000511	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism of lipids and lipoproteins—CYP11A1—epilepsy syndrome	4.32e-05	0.000509	CbGpPWpGaD
Gadoxetate—SLCO1B1—Transmembrane transport of small molecules—AQP1—epilepsy syndrome	4.28e-05	0.000505	CbGpPWpGaD
Gadoxetate—ABCC2—Transmembrane transport of small molecules—SLC8A1—epilepsy syndrome	4.27e-05	0.000503	CbGpPWpGaD
Gadoxetate—Vomiting—Pregabalin—epilepsy syndrome	4.26e-05	0.000212	CcSEcCtD
Gadoxetate—Feeling abnormal—Topiramate—epilepsy syndrome	4.26e-05	0.000212	CcSEcCtD
Gadoxetate—ABCC3—Transmembrane transport of small molecules—ABCG2—epilepsy syndrome	4.24e-05	0.0005	CbGpPWpGaD
Gadoxetate—Gastrointestinal pain—Topiramate—epilepsy syndrome	4.23e-05	0.00021	CcSEcCtD
Gadoxetate—Rash—Pregabalin—epilepsy syndrome	4.22e-05	0.00021	CcSEcCtD
Gadoxetate—Dermatitis—Pregabalin—epilepsy syndrome	4.22e-05	0.00021	CcSEcCtD
Gadoxetate—Diarrhoea—Gabapentin—epilepsy syndrome	4.2e-05	0.000209	CcSEcCtD
Gadoxetate—ABCC4—Platelet activation, signaling and aggregation—PRKCB—epilepsy syndrome	4.2e-05	0.000495	CbGpPWpGaD
Gadoxetate—Headache—Pregabalin—epilepsy syndrome	4.2e-05	0.000209	CcSEcCtD
Gadoxetate—SLCO1B3—Metabolism—GBE1—epilepsy syndrome	4.19e-05	0.000494	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—PPP1R3C—epilepsy syndrome	4.19e-05	0.000494	CbGpPWpGaD
Gadoxetate—SLCO1B1—Transmembrane transport of small molecules—TRPV1—epilepsy syndrome	4.17e-05	0.000491	CbGpPWpGaD
Gadoxetate—ABCC3—Transmembrane transport of small molecules—ATP2A2—epilepsy syndrome	4.13e-05	0.000487	CbGpPWpGaD
Gadoxetate—ABCC2—Transmembrane transport of small molecules—SLC1A3—epilepsy syndrome	4.12e-05	0.000486	CbGpPWpGaD
Gadoxetate—ABCC2—Transmembrane transport of small molecules—AQP4—epilepsy syndrome	4.12e-05	0.000486	CbGpPWpGaD
Gadoxetate—Urticaria—Topiramate—epilepsy syndrome	4.11e-05	0.000204	CcSEcCtD
Gadoxetate—SLCO1B3—Metabolism of lipids and lipoproteins—BCHE—epilepsy syndrome	4.1e-05	0.000483	CbGpPWpGaD
Gadoxetate—Abdominal pain—Topiramate—epilepsy syndrome	4.09e-05	0.000203	CcSEcCtD
Gadoxetate—Body temperature increased—Topiramate—epilepsy syndrome	4.09e-05	0.000203	CcSEcCtD
Gadoxetate—ABCC3—Metabolism—NEU1—epilepsy syndrome	4.07e-05	0.000479	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—UPB1—epilepsy syndrome	4.07e-05	0.000479	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—ATIC—epilepsy syndrome	4.07e-05	0.000479	CbGpPWpGaD
Gadoxetate—Dizziness—Gabapentin—epilepsy syndrome	4.06e-05	0.000202	CcSEcCtD
Gadoxetate—SLCO1B1—Transmembrane transport of small molecules—SLC8A1—epilepsy syndrome	4.01e-05	0.000473	CbGpPWpGaD
Gadoxetate—SLCO1B1—SLC-mediated transmembrane transport—AVP—epilepsy syndrome	4e-05	0.000472	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—GAMT—epilepsy syndrome	4e-05	0.000471	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—NHLRC1—epilepsy syndrome	4e-05	0.000471	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—EPM2A—epilepsy syndrome	4e-05	0.000471	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—PNPO—epilepsy syndrome	4e-05	0.000471	CbGpPWpGaD
Gadoxetate—ABCC4—Transmembrane transport of small molecules—ABCG2—epilepsy syndrome	3.99e-05	0.00047	CbGpPWpGaD
Gadoxetate—Nausea—Pregabalin—epilepsy syndrome	3.98e-05	0.000198	CcSEcCtD
Gadoxetate—SLCO1B3—Metabolism—ASAH1—epilepsy syndrome	3.94e-05	0.000464	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—HSD17B4—epilepsy syndrome	3.92e-05	0.000461	CbGpPWpGaD
Gadoxetate—Vomiting—Gabapentin—epilepsy syndrome	3.91e-05	0.000194	CcSEcCtD
Gadoxetate—SLCO1B3—Transmembrane transport of small molecules—PLAT—epilepsy syndrome	3.89e-05	0.000459	CbGpPWpGaD
Gadoxetate—ABCC4—Transmembrane transport of small molecules—ATP2A2—epilepsy syndrome	3.89e-05	0.000458	CbGpPWpGaD
Gadoxetate—SLCO1B1—Transmembrane transport of small molecules—AQP4—epilepsy syndrome	3.87e-05	0.000457	CbGpPWpGaD
Gadoxetate—SLCO1B1—Transmembrane transport of small molecules—SLC1A3—epilepsy syndrome	3.87e-05	0.000457	CbGpPWpGaD
Gadoxetate—Rash—Gabapentin—epilepsy syndrome	3.87e-05	0.000193	CcSEcCtD
Gadoxetate—Dermatitis—Gabapentin—epilepsy syndrome	3.87e-05	0.000192	CcSEcCtD
Gadoxetate—Headache—Gabapentin—epilepsy syndrome	3.85e-05	0.000191	CcSEcCtD
Gadoxetate—SLCO1B3—Metabolism—STXBP1—epilepsy syndrome	3.83e-05	0.000452	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—ADRA2A—epilepsy syndrome	3.83e-05	0.000452	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—PLAT—epilepsy syndrome	3.82e-05	0.00045	CbGpPWpGaD
Gadoxetate—Hypersensitivity—Topiramate—epilepsy syndrome	3.81e-05	0.000189	CcSEcCtD
Gadoxetate—ABCC3—Metabolism—PPP1R3C—epilepsy syndrome	3.78e-05	0.000446	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—GBE1—epilepsy syndrome	3.78e-05	0.000446	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—NT5E—epilepsy syndrome	3.74e-05	0.00044	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—ALAD—epilepsy syndrome	3.74e-05	0.00044	CbGpPWpGaD
Gadoxetate—SLCO1B3—Transmembrane transport of small molecules—SLC2A1—epilepsy syndrome	3.72e-05	0.000438	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—QDPR—epilepsy syndrome	3.72e-05	0.000438	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—CA4—epilepsy syndrome	3.72e-05	0.000438	CbGpPWpGaD
Gadoxetate—SLCO1B1—Transmembrane transport of small molecules—ABCC2—epilepsy syndrome	3.71e-05	0.000438	CbGpPWpGaD
Gadoxetate—Asthenia—Topiramate—epilepsy syndrome	3.71e-05	0.000184	CcSEcCtD
Gadoxetate—ABCC3—Metabolism of lipids and lipoproteins—BCHE—epilepsy syndrome	3.7e-05	0.000436	CbGpPWpGaD
Gadoxetate—ABCC2—Transmembrane transport of small molecules—SLC6A1—epilepsy syndrome	3.68e-05	0.000433	CbGpPWpGaD
Gadoxetate—Pruritus—Topiramate—epilepsy syndrome	3.66e-05	0.000182	CcSEcCtD
Gadoxetate—Nausea—Gabapentin—epilepsy syndrome	3.65e-05	0.000181	CcSEcCtD
Gadoxetate—SLCO1B3—SLC-mediated transmembrane transport—ALB—epilepsy syndrome	3.61e-05	0.000426	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—NOS1—epilepsy syndrome	3.59e-05	0.000423	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—ALDH7A1—epilepsy syndrome	3.56e-05	0.00042	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—CACNA1A—epilepsy syndrome	3.56e-05	0.00042	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—ASAH1—epilepsy syndrome	3.56e-05	0.000419	CbGpPWpGaD
Gadoxetate—Diarrhoea—Topiramate—epilepsy syndrome	3.54e-05	0.000176	CcSEcCtD
Gadoxetate—ABCC3—Transmembrane transport of small molecules—PLAT—epilepsy syndrome	3.51e-05	0.000414	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—COX3—epilepsy syndrome	3.49e-05	0.000412	CbGpPWpGaD
Gadoxetate—ABCC4—Platelet activation, signaling and aggregation—ALB—epilepsy syndrome	3.49e-05	0.000411	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—ST3GAL3—epilepsy syndrome	3.49e-05	0.000411	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—STXBP1—epilepsy syndrome	3.46e-05	0.000408	CbGpPWpGaD
Gadoxetate—SLCO1B1—Transmembrane transport of small molecules—SLC6A1—epilepsy syndrome	3.45e-05	0.000407	CbGpPWpGaD
Gadoxetate—Dizziness—Topiramate—epilepsy syndrome	3.42e-05	0.00017	CcSEcCtD
Gadoxetate—SLCO1B3—Metabolism—ADSL—epilepsy syndrome	3.42e-05	0.000403	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—ALAD—epilepsy syndrome	3.37e-05	0.000397	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—NT5E—epilepsy syndrome	3.37e-05	0.000397	CbGpPWpGaD
Gadoxetate—ABCC2—Transmembrane transport of small molecules—ABCG2—epilepsy syndrome	3.36e-05	0.000396	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—AKT3—epilepsy syndrome	3.36e-05	0.000396	CbGpPWpGaD
Gadoxetate—ABCC3—Transmembrane transport of small molecules—SLC2A1—epilepsy syndrome	3.35e-05	0.000395	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—GLUL—epilepsy syndrome	3.35e-05	0.000395	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—PLAUR—epilepsy syndrome	3.32e-05	0.000391	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—CACNA2D2—epilepsy syndrome	3.31e-05	0.00039	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—SLC6A8—epilepsy syndrome	3.31e-05	0.00039	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—SLCO1A2—epilepsy syndrome	3.31e-05	0.00039	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—KCNB1—epilepsy syndrome	3.31e-05	0.00039	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—PFKL—epilepsy syndrome	3.31e-05	0.00039	CbGpPWpGaD
Gadoxetate—ABCC4—Transmembrane transport of small molecules—PLAT—epilepsy syndrome	3.3e-05	0.000389	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—CACNA1D—epilepsy syndrome	3.29e-05	0.000388	CbGpPWpGaD
Gadoxetate—Vomiting—Topiramate—epilepsy syndrome	3.29e-05	0.000163	CcSEcCtD
Gadoxetate—ABCC2—Transmembrane transport of small molecules—ATP2A2—epilepsy syndrome	3.28e-05	0.000386	CbGpPWpGaD
Gadoxetate—Rash—Topiramate—epilepsy syndrome	3.26e-05	0.000162	CcSEcCtD
Gadoxetate—Dermatitis—Topiramate—epilepsy syndrome	3.26e-05	0.000162	CcSEcCtD
Gadoxetate—Headache—Topiramate—epilepsy syndrome	3.24e-05	0.000161	CcSEcCtD
Gadoxetate—SLCO1B1—Metabolism of lipids and lipoproteins—CYP2C19—epilepsy syndrome	3.24e-05	0.000381	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism of lipids and lipoproteins—CYP11A1—epilepsy syndrome	3.22e-05	0.000379	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—CACNA1A—epilepsy syndrome	3.22e-05	0.000379	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—ALDH7A1—epilepsy syndrome	3.22e-05	0.000379	CbGpPWpGaD
Gadoxetate—SLCO1B1—Transmembrane transport of small molecules—ABCG2—epilepsy syndrome	3.16e-05	0.000372	CbGpPWpGaD
Gadoxetate—ABCC4—Transmembrane transport of small molecules—SLC2A1—epilepsy syndrome	3.15e-05	0.000372	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—ST3GAL3—epilepsy syndrome	3.15e-05	0.000371	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—ADSL—epilepsy syndrome	3.08e-05	0.000363	CbGpPWpGaD
Gadoxetate—SLCO1B1—Transmembrane transport of small molecules—ATP2A2—epilepsy syndrome	3.08e-05	0.000363	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—TXNRD1—epilepsy syndrome	3.08e-05	0.000363	CbGpPWpGaD
Gadoxetate—Nausea—Topiramate—epilepsy syndrome	3.07e-05	0.000153	CcSEcCtD
Gadoxetate—ABCC4—Hemostasis—CDC42—epilepsy syndrome	3.07e-05	0.000361	CbGpPWpGaD
Gadoxetate—SLCO1B3—Transmembrane transport of small molecules—HMOX1—epilepsy syndrome	3.06e-05	0.00036	CbGpPWpGaD
Gadoxetate—SLCO1B3—Transmembrane transport of small molecules—AVP—epilepsy syndrome	3.03e-05	0.000357	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—UPB1—epilepsy syndrome	3.03e-05	0.000357	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—ATIC—epilepsy syndrome	3.03e-05	0.000357	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—NEU1—epilepsy syndrome	3.03e-05	0.000357	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—GLUL—epilepsy syndrome	3.02e-05	0.000356	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—AQP1—epilepsy syndrome	2.99e-05	0.000352	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—CACNA1D—epilepsy syndrome	2.97e-05	0.00035	CbGpPWpGaD
Gadoxetate—SLCO1B3—Transmembrane transport of small molecules—ABCB1—epilepsy syndrome	2.93e-05	0.000346	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—HSD17B4—epilepsy syndrome	2.92e-05	0.000344	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	2.87e-05	0.000338	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—GBE1—epilepsy syndrome	2.82e-05	0.000332	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—PPP1R3C—epilepsy syndrome	2.82e-05	0.000332	CbGpPWpGaD
Gadoxetate—ABCC2—Transmembrane transport of small molecules—PLAT—epilepsy syndrome	2.79e-05	0.000328	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—TXNRD1—epilepsy syndrome	2.78e-05	0.000327	CbGpPWpGaD
Gadoxetate—ABCC3—Transmembrane transport of small molecules—HMOX1—epilepsy syndrome	2.76e-05	0.000325	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism of lipids and lipoproteins—BCHE—epilepsy syndrome	2.75e-05	0.000324	CbGpPWpGaD
Gadoxetate—ABCC3—Transmembrane transport of small molecules—AVP—epilepsy syndrome	2.73e-05	0.000322	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—FYN—epilepsy syndrome	2.73e-05	0.000322	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—KCNJ11—epilepsy syndrome	2.7e-05	0.000318	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—CHRM3—epilepsy syndrome	2.7e-05	0.000318	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—AQP1—epilepsy syndrome	2.69e-05	0.000318	CbGpPWpGaD
Gadoxetate—ABCC2—Transmembrane transport of small molecules—SLC2A1—epilepsy syndrome	2.66e-05	0.000313	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—ASAH1—epilepsy syndrome	2.65e-05	0.000312	CbGpPWpGaD
Gadoxetate—ABCC3—Transmembrane transport of small molecules—ABCB1—epilepsy syndrome	2.65e-05	0.000312	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—YWHAZ—epilepsy syndrome	2.62e-05	0.000309	CbGpPWpGaD
Gadoxetate—SLCO1B1—Transmembrane transport of small molecules—PLAT—epilepsy syndrome	2.62e-05	0.000308	CbGpPWpGaD
Gadoxetate—ABCC4—Transmembrane transport of small molecules—HMOX1—epilepsy syndrome	2.59e-05	0.000306	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	2.59e-05	0.000305	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—STXBP1—epilepsy syndrome	2.58e-05	0.000304	CbGpPWpGaD
Gadoxetate—ABCC4—Transmembrane transport of small molecules—AVP—epilepsy syndrome	2.57e-05	0.000303	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	2.51e-05	0.000296	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—NT5E—epilepsy syndrome	2.51e-05	0.000296	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—ALAD—epilepsy syndrome	2.51e-05	0.000296	CbGpPWpGaD
Gadoxetate—SLCO1B1—Transmembrane transport of small molecules—SLC2A1—epilepsy syndrome	2.5e-05	0.000294	CbGpPWpGaD
Gadoxetate—ABCC4—Transmembrane transport of small molecules—ABCB1—epilepsy syndrome	2.49e-05	0.000293	CbGpPWpGaD
Gadoxetate—ABCC4—Platelet activation, signaling and aggregation—SRC—epilepsy syndrome	2.47e-05	0.000291	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	2.46e-05	0.00029	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—KCNJ11—epilepsy syndrome	2.44e-05	0.000287	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—CHRM3—epilepsy syndrome	2.44e-05	0.000287	CbGpPWpGaD
Gadoxetate—SLCO1B1—SLC-mediated transmembrane transport—ALB—epilepsy syndrome	2.43e-05	0.000286	CbGpPWpGaD
Gadoxetate—ABCC4—Platelet activation, signaling and aggregation—VEGFA—epilepsy syndrome	2.4e-05	0.000283	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—CACNA1A—epilepsy syndrome	2.39e-05	0.000282	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—ALDH7A1—epilepsy syndrome	2.39e-05	0.000282	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—ST3GAL3—epilepsy syndrome	2.34e-05	0.000276	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—PLAU—epilepsy syndrome	2.33e-05	0.000275	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—ADSL—epilepsy syndrome	2.3e-05	0.000271	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	2.27e-05	0.000267	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—GLUL—epilepsy syndrome	2.25e-05	0.000265	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	2.22e-05	0.000262	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—CACNA1D—epilepsy syndrome	2.21e-05	0.00026	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—ABCG2—epilepsy syndrome	2.2e-05	0.000259	CbGpPWpGaD
Gadoxetate—ABCC2—Transmembrane transport of small molecules—HMOX1—epilepsy syndrome	2.19e-05	0.000258	CbGpPWpGaD
Gadoxetate—ABCC2—Transmembrane transport of small molecules—AVP—epilepsy syndrome	2.17e-05	0.000255	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—PRKCB—epilepsy syndrome	2.17e-05	0.000255	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—CYP2C19—epilepsy syndrome	2.15e-05	0.000253	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—NOS2—epilepsy syndrome	2.14e-05	0.000252	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—CYP11A1—epilepsy syndrome	2.13e-05	0.000251	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	2.12e-05	0.00025	CbGpPWpGaD
Gadoxetate—ABCC2—Transmembrane transport of small molecules—ABCB1—epilepsy syndrome	2.1e-05	0.000247	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—TXNRD1—epilepsy syndrome	2.07e-05	0.000244	CbGpPWpGaD
Gadoxetate—SLCO1B1—Transmembrane transport of small molecules—HMOX1—epilepsy syndrome	2.05e-05	0.000242	CbGpPWpGaD
Gadoxetate—SLCO1B1—Transmembrane transport of small molecules—AVP—epilepsy syndrome	2.04e-05	0.00024	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—AQP1—epilepsy syndrome	2.01e-05	0.000236	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—ABCG2—epilepsy syndrome	1.99e-05	0.000234	CbGpPWpGaD
Gadoxetate—SLCO1B1—Transmembrane transport of small molecules—ABCB1—epilepsy syndrome	1.97e-05	0.000232	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—CYP2C19—epilepsy syndrome	1.94e-05	0.000228	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	1.93e-05	0.000227	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	1.93e-05	0.000227	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—CYP2D6—epilepsy syndrome	1.92e-05	0.000227	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—CYP11A1—epilepsy syndrome	1.92e-05	0.000227	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	1.91e-05	0.000225	CbGpPWpGaD
Gadoxetate—SLCO1B3—Transmembrane transport of small molecules—ALB—epilepsy syndrome	1.84e-05	0.000216	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—ADRA2A—epilepsy syndrome	1.83e-05	0.000216	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—BCHE—epilepsy syndrome	1.82e-05	0.000215	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—KCNJ11—epilepsy syndrome	1.81e-05	0.000214	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—CHRM3—epilepsy syndrome	1.81e-05	0.000214	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—ALB—epilepsy syndrome	1.8e-05	0.000212	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	1.74e-05	0.000205	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—SLC2A1—epilepsy syndrome	1.74e-05	0.000205	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—CYP2D6—epilepsy syndrome	1.74e-05	0.000205	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—PLCB1—epilepsy syndrome	1.72e-05	0.000203	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—TH—epilepsy syndrome	1.72e-05	0.000202	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	1.69e-05	0.000199	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	1.69e-05	0.000199	CbGpPWpGaD
Gadoxetate—ABCC3—Transmembrane transport of small molecules—ALB—epilepsy syndrome	1.66e-05	0.000195	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	1.66e-05	0.000195	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—ADRA2A—epilepsy syndrome	1.65e-05	0.000195	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—BCHE—epilepsy syndrome	1.65e-05	0.000194	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—SLC2A1—epilepsy syndrome	1.57e-05	0.000185	CbGpPWpGaD
Gadoxetate—ABCC4—Transmembrane transport of small molecules—ALB—epilepsy syndrome	1.56e-05	0.000183	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—PLCB1—epilepsy syndrome	1.55e-05	0.000183	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—TH—epilepsy syndrome	1.55e-05	0.000182	CbGpPWpGaD
Gadoxetate—ABCC4—Platelet activation, signaling and aggregation—AKT1—epilepsy syndrome	1.53e-05	0.000181	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	1.52e-05	0.00018	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—ABCG2—epilepsy syndrome	1.48e-05	0.000174	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—CYP2C19—epilepsy syndrome	1.44e-05	0.00017	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—CYP11A1—epilepsy syndrome	1.43e-05	0.000169	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—HMOX1—epilepsy syndrome	1.43e-05	0.000169	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	1.42e-05	0.000168	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—CAT—epilepsy syndrome	1.41e-05	0.000166	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—ABCB1—epilepsy syndrome	1.37e-05	0.000162	CbGpPWpGaD
Gadoxetate—ABCC2—Transmembrane transport of small molecules—ALB—epilepsy syndrome	1.31e-05	0.000155	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	1.3e-05	0.000153	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—CYP2D6—epilepsy syndrome	1.29e-05	0.000152	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—HMOX1—epilepsy syndrome	1.29e-05	0.000152	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—GPX1—epilepsy syndrome	1.28e-05	0.000151	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—CAT—epilepsy syndrome	1.27e-05	0.00015	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—SRC—epilepsy syndrome	1.27e-05	0.00015	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—ABCB1—epilepsy syndrome	1.24e-05	0.000146	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—VEGFA—epilepsy syndrome	1.24e-05	0.000146	CbGpPWpGaD
Gadoxetate—SLCO1B1—Transmembrane transport of small molecules—ALB—epilepsy syndrome	1.23e-05	0.000145	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—ADRA2A—epilepsy syndrome	1.23e-05	0.000145	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—BCHE—epilepsy syndrome	1.23e-05	0.000144	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—SLC2A1—epilepsy syndrome	1.17e-05	0.000138	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—PLCB1—epilepsy syndrome	1.16e-05	0.000136	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—GPX1—epilepsy syndrome	1.15e-05	0.000136	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—TH—epilepsy syndrome	1.15e-05	0.000136	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	1.13e-05	0.000134	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—AGT—epilepsy syndrome	1.12e-05	0.000132	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—APOE—epilepsy syndrome	1.1e-05	0.000129	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—AGT—epilepsy syndrome	1.01e-05	0.000119	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—APOE—epilepsy syndrome	9.9e-06	0.000117	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—HMOX1—epilepsy syndrome	9.62e-06	0.000113	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—CAT—epilepsy syndrome	9.49e-06	0.000112	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—POMC—epilepsy syndrome	9.43e-06	0.000111	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—ABCB1—epilepsy syndrome	9.23e-06	0.000109	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—ALB—epilepsy syndrome	8.59e-06	0.000101	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—GPX1—epilepsy syndrome	8.58e-06	0.000101	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—POMC—epilepsy syndrome	8.51e-06	0.0001	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—AKT1—epilepsy syndrome	7.91e-06	9.32e-05	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—ALB—epilepsy syndrome	7.76e-06	9.14e-05	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—AGT—epilepsy syndrome	7.53e-06	8.87e-05	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—PTGS2—epilepsy syndrome	7.52e-06	8.86e-05	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—APOE—epilepsy syndrome	7.37e-06	8.69e-05	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—PTGS2—epilepsy syndrome	6.78e-06	8e-05	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—POMC—epilepsy syndrome	6.33e-06	7.47e-05	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—ALB—epilepsy syndrome	5.77e-06	6.81e-05	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—PTGS2—epilepsy syndrome	5.05e-06	5.95e-05	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—AKT1—epilepsy syndrome	3.78e-06	4.45e-05	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—AKT1—epilepsy syndrome	3.41e-06	4.02e-05	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—AKT1—epilepsy syndrome	2.54e-06	2.99e-05	CbGpPWpGaD
